Finding genes that affect acute intermittent porphyria
Part of Digestive system, Genetic & congenital, Hormones & metabolism, Skin clinical trials.
This study aims to find genes that may affect acute intermittent porphyria (AIP), a rare genetic condition that can cause sudden, severe attacks. By studying blood, saliva, and urine from family members, researchers hope to better understand and possibly improve treatment for this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 years old or older.
- You are part of a family affected by acute intermittent porphyria (AIP).
- You are willing to provide blood or saliva and urine samples.
- You are able to give your permission to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the genes that may be linked to pulmonary hypertension. By providing a saliva sample and filling out a health survey from home, you can help researchers learn more about this condition.
This trial tests whether a diet high in carbohydrates can help treat acute intermittent porphyria (AIP), a condition that can cause attacks of pain and other symptoms. If you have AIP, this study wants to see if eating more carbs can prevent or manage attacks.
This study follows people with porphyria over time to learn more about the disease, its symptoms, and how it affects daily life. By tracking patients, researchers hope to improve care and understanding of this rare group of conditions.
This study is a registry (a list) of people diagnosed with acute hepatic porphyria. It helps researchers learn about the condition and track health information over time; it doesn’t test a new drug in the way treatment trials do.
This study tracks how your body reacts to sunlight if you have erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP)—rare genetic conditions that cause painful skin reactions to sun exposure. Researchers will use special devices and daily logs to better understand your symptoms and how light affects your skin.
This study aims to learn more about rare disorders of purine and pyrimidine metabolism (DPPM), which can affect the brain, immune system, kidneys, and muscles. Researchers will study people with these disorders, their family members, and healthy volunteers to better understand the condition over time.
Hear when a new Acute Intermittent Porphyria (AIP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.